Involvement of cyclooxygenase 2 and prostaglandin E2 in the effects of insulin on gastric emptying in male rats

Journal of Physiology and Pharmacology

Volumn 60, Issue 3, 2009, Pages 109-118

  Huang, W J ^a   Hung, C R ^b   Chen, M C ^a   Wang, J R ^a   Doong, M L ^a   Wang, C K ^c   Hung, C T ^c   Wang, Paulus S ^a,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

Cyclooxygenase 2; Diabetes mellitus; Gastrointestinal motility; Insulin; Prostaglandin E2

Indexed keywords

ATROPINE; CHOLECYSTOKININ; CYCLOOXYGENASE 2; INDOMETACIN; INSULIN; INSULIN RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLECYSTOKININ BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; GASTROINTESTINAL MOTILITY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE CONTRACTION; STOMACH EMPTYING; STOMACH MUSCLE; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD GLUCOSE; BLOTTING, WESTERN; CYCLOOXYGENASE 2; DIABETES MELLITUS, EXPERIMENTAL; DINOPROSTONE; GASTRIC EMPTYING; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, INSULIN; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M3; STOMACH;

EID: 70350234663     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Hubinger A. Diabetes mellitus-most frequently occurring metabolic diseases. Krankenpflege (Frankf) 1985; 39:243-245.
2. Shestakova MV, Butrova SA, Sukhareva O. Metabolic syndrome as a precursor of diabetes mellitus type 2 and cardiovascular diseases. Ter Arkh 2007; 79: 5-8.
3. Kristiansen OP, Pociot F, Bennett EP, et al. IDDM7 links to insulin-dependent diabetes mellitus in Danish multiplex families but linkage is not explained by novel polymorphisms in the candidate gene GALNT3. The Danish Study Group of Diabetes in Childhood and The Danish IDDM Epidemiology and Genetics Group. Hum Mutat 2000; 15: 295-296.
4. Ihm SH, Lee KU, Yoon JW. Studies on autoimmunity for initiation of beta-cell destruction. VII. Evidence for antigenic changes on beta-cells leading to autoimmune destruction of beta-cells in BB rats. Diabetes 1991; 40: 269-274.
5. Langeveld M, de Fost M, Aerts JM, Sauerwein HP, Hollak CE. Overweight, insulin resistance and type II diabetes in type I Gaucher disease patients in relation to enzyme replacement therapy. Blood Cells Mol Dis 2008; 40: 428-432.
6. Os I, Os A, Abdelnoor M, Larsen A, Birkeland K, Westheim A. Insulin sensitivity in women with coronary heart disease during hormone replacement therapy. J Womens Health (Larchmt) 2005; 14: 137-145. (Pubitemid 40567991)
7. Fellows IW, Evans DF, Bennett T, Macdonald IA, Clark AG, Bloom SR. The effect of insulin-induced hypoglycaemia on gastrointestinal motility in man. Clin Sci (Lond) 1987; 72: 743-748. (Pubitemid 17077537)
8. Horowitz M, Edelbroek M, Fraser R, Maddox A, Wishart J. Disordered gastric motor function in diabetes mellitus. Recent insights into prevalence, pathophysiology, clinical relevance, and treatment. Scand J Gastroenterol 1991; 26: 673-684.
9. Yamamoto T, Watabe K, Nakahara M, et al. Disturbed gastrointestinal motility and decreased interstitial cells of Cajal in diabetic db/db mice. J Gastroenterol Hepatol 2008; 23: 660-667.
10. Gao Y, Guo XH, Vaz JA. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: Chinese Present study. Diabetes Obes Metab 2009; 11: 33-40.
11. Jeandidier N, Riveline JP, Tubiana-Rufi N, et al. Treatment of diabetes mellitus using an external insulin pump in clinical practice. Diabetes Metab 2008; 34: 425-438.
12. Keshavarzian A, Iber FL. Gastrointestinal involvement in insulin-requiring diabetes mellitus. J Clin Gastroenterol 1987; 9: 685-692. (Pubitemid 18055993)
13. Keshavarzian A, Iber FL, Vaeth J. Gastric emptying in patients with insulin-requiring diabetes mellitus. Am J Gastroenterol 1987; 82: 29-35. (Pubitemid 17231680)
14. Kulkarni PS. Synthesis of cyclooxygenase products by human anterior uvea from cyclic prostaglandin endoperoxide (PGH2). Exp Eye Res 1981; 32: 197-204.
15. Messina EJ, Rodenburg J, Slomiany BL, Roberts AM, Hintze TH, Kaley G. Microcirculatory effects of arachidonic acid and a prostaglandin endoperoxide (PGH2). Microvasc Res 1980; 19: 288-296. (Pubitemid 10043774)
16. Narita M, Shimamura M, Imai S, et al. Role of interleukin- 1beta and tumor necrosis factor-alpha-dependent expression of cyclooxygenase-2 mRNA in thermal hyperalgesia induced by chronic inflammation in mice. Neuroscience 2008; 152: 477-486.
17. Tsatsanis C, Androulidaki A, Dermitzaki E, Gravanis A, Margioris AN. Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPSinduced TNF-alpha release from macrophages via induction of COX-2 and PGE2. J Cell Physiol 2007; 210: 774-783. (Pubitemid 46185047)
18. Faour WH, Gomi K, Kennedy CR. PGE2 induces COX-2 expression in podocytes via the EP4 receptor through a PKAindependent mechanism. Cell Signal 2008; 20: 2156-2164.
19. Leo C, Faber S, Hentschel B, Hockel M, Horn LC. The status of cyclooxygenase-2 expression in ductal carcinoma in situ lesions and invasive breast cancer correlates to cyclooxygenase-2 expression in normal breast tissue. Ann Diagn Pathol 2006; 10: 327-332. (Pubitemid 44765274)
20. Wu CY, Lee WH, Wang JY, et al. Tissue microarray-determined expression profiles of cyclooxygenase-2 in colorectal adenocarcinoma: association with clinicopathological parameters. Chin J Physiol 2006; 49: 298-304.
21. Guo Z, Su W, Allen S, et al. COX-2 up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice. Cardiovasc Res 2005; 67: 723-735. (Pubitemid 41033368)
22. Taniguchi M. Physiopathology and treatment of aspirin (NSAID) intolerance. Nippon Naika Gakkai Zasshi 2006; 95: 148-157.
23. Aabakken L. NSAID-associated gastrointestinal damage: methodological considerations and a review of the experience with enteric coated naproxen. Eur J Rheumatol Inflamm 1992; 12: 9-20.
24. Dobrek L, Nowakowski M, Mazur M, Herman RM, Thor PJ. Disturbances of the parasympathetic branch of the autonomic nervous system in patients with gastroesophageal reflux disease (GERD) estimated by short-term heart rate variability recordings. J Physiol Pharmacol 2004; 55(Suppl 2): 77-90.
25. Searl TJ, Cunnane TC. Neurotransmitter release mechanisms in sympathetic and parasympathetic nerve terminals. Biochem Soc Trans 1993; 21: 416-420. (Pubitemid 23167936)
26. Takai N, Shida T, Uchihashi K, Ueda Y, Yoshida Y. Cholecystokinin as neurotransmitter and neuromodulator in parasympathetic secretion in the rat submandibular gland. Ann N Y Acad Sci 1998; 842: 199-203. (Pubitemid 28227024)
27. Saji M, Miura M. Nicotinic and muscarinic property of ACh receptors on cultured brain stem neurons. Jpn J Physiol 1982; 32: 1015-1021. (Pubitemid 13162441)
28. Stone WS, Cottrill KL, Walker DL, Gold PE. Blood glucose and brain function: interactions with CNS cholinergic systems. Behav Neural Biol 1988; 50: 325-334.
29. Bonaz B. The cholinergic anti-inflammatory pathway and the gastrointestinal tract. Gastroenterology 2007; 133: 1370-1373. (Pubitemid 47494485)
30. Luo W, Latchney LR, Culp DJ. G protein coupling to M1 and M3 muscarinic receptors in sublingual glands. Am J Physiol Cell Physiol 2001; 280: C884-C896.
31. Ghayur MN, Khan AH, Gilani AH. Ginger facilitates cholinergic activity possibly due to blockade of muscarinic autoreceptors in rat stomach fundus. Pak J Pharm Sci 2007; 20: 231-235.
32. Proctor GB. Muscarinic receptors and salivary secretion. J Appl Physiol 2006; 100: 1103-1104.
33. Yamashita T, Kokubun S. Calcium channel modulation by M3 receptor in guinea-pig tracheal smooth muscle cells. Jpn J Pharmacol 1992; 58(Suppl 2): 404P.
34. Heptulla RA, Rodriguez LM, Mason KJ, Haymond MW. Gastric emptying and postprandial glucose excursions in adolescents with type 1 diabetes. Pediatr Diabetes 2008; 9: 561-566.
35. Tack J. Gastric motor disorders. Best Pract Res Clin Gastroenterol 2007; 21: 633-644.
36. Woerle HJ, Albrecht M, Linke R, et al. Impaired hyperglycemia-induced delay in gastric emptying in patients with type 1 diabetes deficient for islet amyloid polypeptide. Diabetes Care 2008; 31: 2325-2331.
37. Schwizer W, Borovicka J, Kunz P, et al. Role of cholecystokinin in the regulation of liquid gastric emptying and gastric motility in humans: studies with the CCK antagonist loxiglumide. Gut 1997; 41: 500-504. (Pubitemid 27448782)
38. Lin S, Kajimura M, Takeuchi K, Kodaira M, Hanai H, Kaneko E. Expression of muscarinic receptor subtypes in rat gastric smooth muscle: effect of M3 selective antagonist on gastric motility and emptying. Dig Dis Sci 1997; 42: 907-914. (Pubitemid 27239779)
39. Ohki Y, Tomomasa T, Tabata M, et al. Delayed gastric emptying in a neonate, associated with a partial defect in the gastric smooth muscle. J Pediatr Surg 1995; 30: 1511-1512.
40. Hsieh HL, Sun CC, Wang TS, Yang CM. PKC-delta/c-Srcmediated EGF receptor transactivation regulates thrombininduced COX-2 expression and PGE2 production in rat vascular smooth muscle cells. Biochim Biophys Acta 2008; 1783: 1563-1575.
41. Kadowaki H, Yamamoto T, Kageyama-Yahara N, Kurokawa N, Kadowaki M. The pathophysiological roles of COX-1 and COX-2 in the intestinal smooth muscle contractility under the anaphylactic condition. Biomed Res 2008; 29: 113-117. (Pubitemid 351753471)
42. Hecking E, Knick B. Nausea and vomiting in diabetes mellitus. Dtsch Med Wochenschr 1972; 97: 1798-1799.
43. Wilm S, Helmert U. The prevalence of fullness, heartburn and nausea among persons with and without diabetes mellitus in Germany. Z Gastroenterol 2006; 44: 373-377. (Pubitemid 43844869)
44. Iciek R, Wender-Ozegowska E, Seremak-Mrozikiewicz A, et al. Leptin gene, leptin gene polymorphisms and body weight in pregnant women with diabetes mellitus type I. J Physiol Pharmacol 2008; 59(Suppl 4): 19-31.
45. Zawiejska A, Wender-Ozegowska E, Brazert J, Sodowski K. Components of metabolic syndrome and their impact on fetal growth in women with gestational diabetes mellitus. J Physiol Pharmacol 2008; 59(Suppl 4): 5-18.
46. Princi T, Delbello G, Grill V, Battigelli D. Role of the parasympathetic autonomic nervous system in digitalis intoxication: electrocardiographic and histological study. Acta Med Croatica 1996; 50: 81-85.
47. Ryberg AT, Selberg H, Soukup O, Gradin K, Tobin G.. Cholinergic submandibular effects and muscarinic receptor expression in blood vessels of the rat. Arch Oral Biol 2008; 53: 605-616.
48. Kitazawa T, Hirama R, Masunaga K, et al. Muscarinic receptor subtypes involved in carbachol-induced contraction of mouse uterine smooth muscle. Naunyn Schmiedebergs Arch Pharmacol 2008; 377: 503-513.
49. Tobin G, Giglio D, Lundgren O. Muscarinic receptor subtypes in the alimentary tract. J Physiol Pharmacol 2009; 60: 3-21.
50. Aihara T, Fujishita T, Kanatani K, et al. Impaired gastric secretion and lack of trophic responses to hypergastrinemia in M3 muscarinic receptor knockout mice. Gastroenterology 2003; 125: 1774-1784. (Pubitemid 37500442)
51. Barboriak JJ, Meade RC. Effect of alcohol on gastric emptying in man. Am J Clin Nutr 1970; 23: 1151-1153.
52. Singer MV, Leffmann C. Alcohol and gastric acid secretion in humans: a short review. Scand J Gastroenterol Suppl 1988; 146: 11-21. (Pubitemid 18227394)
53. Yeomans ND, Dent J. Personal review: alarmism or legitimate concerns about long-term suppression of gastric acid secretion? Aliment Pharmacol Ther 2000; 14: 267-271. (Pubitemid 30145313)
54. Bank S, Marks IN, Louw JH, Tigler-Wybrandi N. Stimulation of gastric-acid secretion by histamine, pentagastrin, and pentagastrin-propantheline after vagotomy in man. Lancet 1967; 2: 67-69.
55. Aihara T, Nakamura Y, Taketo MM, Matsui M, Okabe S. Cholinergically stimulated gastric acid secretion is mediated by M(3) and M(5) but not M(1) muscarinic acetylcholine receptors in mice. Am J Physiol Gastrointest Liver Physiol 2005; 288: G1199-G1207. (Pubitemid 40741073)
56. Kelner MJ, Uglik SF. Mechanism of prostaglandin E2 release and increase in PGH2/PGE2 isomerase activity by PDGF: involvement of nitric oxide. Arch Biochem Biophys 1994; 312: 240-243.
57. Ruan YC, Wang Z, Du JY, et al. Regulation of smooth muscle contractility by the epithelium in rat vas deferens: role of ATP-induced release of PGE2. J Physiol 2008; 586: 4843-4857.
58. Crofford LJ. COX-1 and COX-2 tissue expression: implications and predictions. J Rheumatol Suppl 1997; 49: 15-19. (Pubitemid 27314722)
59. Creminon C, Habib A, Maclouf J, Pradelles P, Grassi J, Frobert Y. Differential measurement of constitutive (COX-1) and inducible (COX-2) cyclooxygenase expression in human umbilical vein endothelial cells using specific immunometric enzyme immunoassays. Biochim Biophys Acta 1995; 1254: 341-348.
60. Dajani EZ, Islam K. Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man. J Physiol Pharmacol 2008; 59(Suppl 2): 117-133.
61. Okabe S, Tabata K, Ishihara Y, Kunimi H, Izumi K, Uchida N. Irritative activity of antiinflammatory agents, betamethasone 17-valerate, beclomethasone 17, 21- dipropionate, betamethasone 17, 21-dipropionate, or indomethacin on the gastrointestinal tract in rats and dogs (author's transl). Nippon Yakurigaku Zasshi 1978; 74: 773-781. (Pubitemid 9056632)
62. Zayachkivska O, Gzregotsky M, Ferentc M, Yaschenko A, Urbanovych A. Effects of nitrosative stress and reactive oxygen-scavenging systems in esophageal physiopathy under streptozotocin-induced experimental hyperglycemia. J Physiol Pharmacol 2008; 59(Suppl 2): 77-87.
63. Kanatani K, Ebata M, Murakami M, Okabe S. Effects of indomethacin and rofecoxib on gastric mucosal damage in normal and Helicobacter pylori-infected mongolian gerbils. J Physiol Pharmacol 2004; 55: 207-222. (Pubitemid 38450987)
64. Takeuchi K, Ueki S, Okabe S. Importance of gastric motility in the pathogenesis of indomethacin-induced gastric lesions in rats. Dig Dis Sci 1986; 31: 1114-1122. (Pubitemid 16025649)
65. Okabe S, Tabata K. Does indomethacin activate healed gastric ulcers in the dog? Digestion 1981; 21: 179-183. (Pubitemid 11183912)
66. Brzozowski T, Konturek PC, Konturek SJ, et al. Involvement of cyclooxygenase (COX)-2 products in acceleration of ulcer healing by gastrin and hepatocyte growth factor. J Physiol Pharmacol 2000; 51: 751-773. (Pubitemid 32049526)
67. Konturek PC, Kania J, Burnat G, Hahn EG, Konturek SJ. Prostaglandins as mediators of COX-2 derived carcinogenesis in gastrointestinal tract. J Physiol Pharmacol 2005; 56(Suppl 5): 57-73.
68. Fischer H, Heidemann T, Hengst K, Domschke W, Konturek JW. Disturbed gastric motility and pancreatic hormone release in diabetes mellitus. J Physiol Pharmacol 1998; 49: 529-541. (Pubitemid 29024371)
69. Liu TT, Shih KC, Kao CC, Cheng WT, Hsieh PS. Importance of cyclooxygenase 2-mediated low-grade inflammation in the development of fructose-induced insulin resistance in rats. Chin J Physiol 2009; 52: 65-71.